Ifp Advisors, Inc Autolus Therapeutics PLC Transaction History

Ifp Advisors, Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 06, 2021	SELL	$5.32 - $7.37 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$4.78 - $7.96 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$5.49 - $9.36 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$8.13 - $12.79 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$11.64 - $16.3 $0 - $0	0 New	0 $0
Q2 2020 Aug 05, 2020	BUY	$5.38 - $16.14 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$4.2 - $13.0 $0 - $0	0 New	0 $0
Q4 2019 Jan 17, 2020	BUY	$11.13 - $16.28 $0 - $0	0 New	0 $0
Q3 2019 Nov 07, 2019	BUY	$9.79 - $16.72 $0 - $0	0 New	0 $0
Q1 2019 May 15, 2019	SELL	$24.38 - $34.71 $1,219 - $1,735	-50 Closed	0 $0
Q4 2018 Jan 23, 2019	BUY	$24.21 - $48.01 $1,210 - $2,400	50 New	50 $1,000

104

163M

2.8K

13.4K

Ticker AUTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,909,800
Market Cap $272M
Description
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.